These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 25325260)

  • 1. Fatal thrombotic thrombocytopenic purpura in a psoriasis patient treated with ustekinumab and methotrexate.
    Philippe L; Badie J; Faller JP; Krattinger É; Deconinck E; Aubin F
    Acta Derm Venereol; 2015 Apr; 95(4):495-6. PubMed ID: 25325260
    [No Abstract]   [Full Text] [Related]  

  • 2. Paradoxical psoriatic arthritis in a patient with psoriasis treated with ustekinumab.
    Čarija A; Ivić I; Marasović-Krstulović D; Puizina-Ivić N
    Rheumatology (Oxford); 2015 Nov; 54(11):2114-6. PubMed ID: 26242857
    [No Abstract]   [Full Text] [Related]  

  • 3. Atopic dermatitis exacerbated with ustekinumab in a psoriatic patient with childhood history of atopy.
    Lis-Święty A; Skrzypek-Salamon A; Arasiewicz H; Brzezińska-Wcisło L
    Allergol Int; 2015 Oct; 64(4):382-3. PubMed ID: 26433537
    [No Abstract]   [Full Text] [Related]  

  • 4. Gastric mucosa-associated lymphoid tissue lymphoma in a patient with severe psoriasis receiving ustekinumab.
    González-Ramos J; Alonso-Pacheco ML; Mayor-Ibarguren A; Herranz-Pinto P
    Actas Dermosifiliogr; 2015 May; 106(4):326-7. PubMed ID: 25529464
    [No Abstract]   [Full Text] [Related]  

  • 5. Worsening of Psoriatic Arthritis After Ustekinumab Treatment.
    Onsun N; Yalcin B; Sallahoglu K; Rezvani A
    Am J Ther; 2018; 25(3):e381-e382. PubMed ID: 29189317
    [No Abstract]   [Full Text] [Related]  

  • 6. Safety of ustekinumab for the treatment of psoriasis vulgaris with myotonic dystrophy.
    Fujita Y; Shinkuma S; Nomura T; Shimizu H
    Eur J Dermatol; 2016 Apr; 26(2):187-8. PubMed ID: 26643260
    [No Abstract]   [Full Text] [Related]  

  • 7. Ustekinumab treatment in patients with psoriasis undergoing hemodialysis.
    Umezawa Y; Hayashi M; Kikuchi S; Fukuchi O; Yanaba K; Ito T; Asahina A; Saeki H; Nakagawa H
    J Dermatol; 2015 Jul; 42(7):731-4. PubMed ID: 25959602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psoriasis vulgaris complicated by eosinophilic pneumonia during ustekinumab treatment.
    Yashiro M; Maejima H; Taniguchi T; Katsuoka K; Kimura M; Wada M
    Eur J Dermatol; 2013; 23(3):396-7. PubMed ID: 23728153
    [No Abstract]   [Full Text] [Related]  

  • 9. Safety of ustekinumab in severe psoriasis with chronic hepatitis B.
    Raymundo AR; Facin AP; Silva de Castro CC; Faria AR
    Indian J Dermatol Venereol Leprol; 2016; 82(3):326-8. PubMed ID: 27088944
    [No Abstract]   [Full Text] [Related]  

  • 10. Onset of psoriatic arthritis during ustekinumab treatment for psoriasis: a case series of seven patients.
    Jones BB; Millsop JW; Walsh JA; Krueger GG; Callis Duffin K
    Br J Dermatol; 2015 Jul; 173(1):272-4. PubMed ID: 25557081
    [No Abstract]   [Full Text] [Related]  

  • 11. Intracranial hypertension syndrome in a patient with psoriasis receiving ustekinumab.
    Reyes Bueno JA; Reyes Garrido V; León A; Bustamante R
    Neurologia (Engl Ed); 2019 May; 34(4):281-282. PubMed ID: 28712842
    [No Abstract]   [Full Text] [Related]  

  • 12. Interstitial pneumonia in two patients with psoriasis during ustekinumab treatment.
    Kikuchi S; Umezawa Y; Hayashi M; Yanaba K; Fukuchi O; Ito T; Asahina A; Saeki H; Nakagawa H
    J Dermatol; 2016 Jun; 43(6):712-3. PubMed ID: 26703791
    [No Abstract]   [Full Text] [Related]  

  • 13. Bullous pemphigoid during ustekinumab therapy in a psoriatic patient.
    Onsun N; Sallahoglu K; Dizman D; Su Ö; Tosuner Z
    Eur J Dermatol; 2017 Feb; 27(1):81-82. PubMed ID: 27777186
    [No Abstract]   [Full Text] [Related]  

  • 14. Thrombotic thrombocytopenic purpura or immune thrombocytopenia in a sickle cell/β+-thalassemia patient: a rare and challenging condition.
    Vlachaki E; Agapidou A; Neokleous N; Adamidou D; Vetsiou E; Boura P
    Transfus Apher Sci; 2014 Oct; 51(2):175-7. PubMed ID: 25266987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple Clustered Dermatofibromas Following Ustekinumab Treatment for
    Ruiz-Villaverde R; Díaz-Martinez MA; Sánchez-Cano D
    Sultan Qaboos Univ Med J; 2017 Aug; 17(3):e375-e377. PubMed ID: 29062570
    [No Abstract]   [Full Text] [Related]  

  • 16. [Ustekinumab-induced eosinophilic pneumonia during the course of ustekinumab therapy for plaque psoriasis].
    Amy de la Bretèque M; Appere-De Vecchi C; Zeboulon C; Zaien I; Sigal ML; Mahé E
    Ann Dermatol Venereol; 2015 Mar; 142(3):193-6. PubMed ID: 25624139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous protothecosis in a patient on ustekinumab for psoriasis.
    Jenkinson H; Thelin L; McAndrew R; Jones KM; Talbott LB; Diven D
    Int J Dermatol; 2018 Oct; 57(10):1246-1248. PubMed ID: 29603193
    [No Abstract]   [Full Text] [Related]  

  • 18. Liver Injury in Psoriasis Patients Receiving Ustekinumab: A Retrospective Study of 44 Patients Treated in the Clinical Practice Setting.
    Llamas-Velasco M; Concha-Garzón MJ; García-Diez A; Daudén E
    Actas Dermosifiliogr; 2015; 106(6):470-6. PubMed ID: 25912374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination use of ustekinumab with other systemic therapies: a retrospective study in a tertiary referral center.
    Heinecke GM; Luber AJ; Levitt JO; Lebwohl MG
    J Drugs Dermatol; 2013 Oct; 12(10):1098-102. PubMed ID: 24085044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of hidradenitis suppurativa in a patient treated with ustekinumab for her psoriasis: A potential paradoxical reaction?
    Gkini MA; Bewley AP
    Dermatol Ther; 2018 Nov; 31(6):e12742. PubMed ID: 30221819
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.